Stonepine Capital Management, LLC
Bend, OR · CIK 1440771 · 13F filing filed 2022-08-12
SEC-registered investment adviser since 2026 · limited liability company
- Assets managed$181.0m
- Staff4 · 3 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $181.0m gross assets
- Websitestonepinecap.com
- Form ADV · 2026-06-26SEC adviser record
- Legal entitySTONEPINE CAPITAL MANAGEMENT, LLC (US)
- Kindhedge funds, futures
- Others nearbyBend, OR, Sausalito, CA
As an employer
- Offices in1 country
- Private fundshedge 2
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Bend, OR (main office)United States | about 1 |
| Sausalito, CA2 officesUnited States | 2 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| AMRYT PHARMA PLC SPONSORED ADS | $44.0m20.48% | Reduced -39.9k |
| CTI BIOPHARMA CORP COM | $22.0m10.23% | Reduced -1.0m |
| XERIS BIOPHARMA HOLDINGS INC XERS | $17.9m8.35% | Added +3.7m |
| ADMA BIOLOGICS INC ADMA | $13.9m6.45% | Reduced -131.8k |
| AMARIN CORP PLC SPONS ADR NEW | $13.2m6.14% | Added +3.9m |
| QUIDELORTHO CORP QDEL | $11.6m5.42% | New |
| REZOLUTE INC RZLT | $9.7m4.51% | Added +2.3m |
| OPTINOSE INC COM | $9.6m4.46% | Reduced -309.9k |
| UROGEN PHARMA LTD URGN | $9.1m4.23% | Added +842.2k |
| LIGAND PHARMACEUTICALS INC LGND | $8.9m4.16% | Added +26.5k |
| AFFIMED N V COM | $8.7m4.05% | New |
| APOLLO ENDOSURGERY INC COM | $7.9m3.67% | Added +468.2k |
| OVID THERAPEUTICS INC OVID | $7.5m3.49% | Reduced -730.1k |
| EXAGEN INC XGN | $7.2m3.37% | Added +139.3k |
| CASTLE BIOSCIENCES INC CSTL | $6.5m3.02% | New |
| CONFORMIS INC CFMS | $6.1m2.85% | Added +23.0k |
| DIAMEDICA THERAPEUTICS INC DMAC | $2.4m1.11% | Reduced -20.9k |
| AERIE PHARMACEUTICALS INC AERI | $1.9m0.88% | Added +157.3k |
| OPIANT PHARMACEUTICALS INC OPNT | $1.8m0.85% | New |
| ATYR PHARMA INC ATYR | $1.7m0.79% | Unchanged |
| MARINUS PHARMACEUTICALS INC MRNS | $1.2m0.55% | Added +185.6k |
| XOMA ROYALTY CORPORATION XOMA | $1.0m0.48% | Added +9.1k |
| ANI PHARMACEUTICALS INC ANIP | $854.0k0.40% | Added +2.7k |
| SYNLOGIC INC COM | $107.0k0.05% | Reduced -971.4k |
| CIDARA THERAPEUTICS INC COM | $102.0k0.05% | Reduced -2.3m |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| ANTARES PHARMA INC ATRS | $12.8m3.1m shares |
| ENANTA PHARMACEUTICALS INC ENTA | $8.5m120.0k shares |
| QUIDEL CORP QDEL | $6.9m61.8k shares |
| EVOLUS INC EOLS | $6.6m586.2k shares |
| SURGALIGN HOLDINGS INC RTIX | $2.2m7.4m shares |
| CELCUITY INC CELC | $2.2m239.4k shares |
| NEUROONE MED TECHNOLOGIES CO | $273.0k248.1k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| QUOIN PHARMACEUTICALS LTD QNRX · 13G · filed 2026-05-15 | 10.0% |
| AEON BIOPHARMA INC AEON · 13G · filed 2026-07-21 | 9.9%≈ $3.9m |
| AZITRA INC 13G · filed 2026-06-22 | 9.9% |
| ELOXX PHARMACEUTICALS INC ELOX · 13G · filed 2026-06-16 | 9.9%≈ $5.6m |
| SINTX TECHNOLOGIES INC SINT · 13G · filed 2026-06-09 | 9.9%≈ $1.2m |
| CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-05-15 | 9.9%≈ $760.7k |
| CELLECTAR BIOSCIENCES INC CLRB · 13G · filed 2026-05-11 | 9.9%≈ $2.4m |
| CURIS INC 13G · filed 2026-03-27 | 9.9%≈ $2.1m |
| IN8BIO INC INAB · 13G · filed 2025-12-22 | 9.9%≈ $1.4m |
| AYTU BIOPHARMA INC AYTU · 13G · filed 2025-08-13 | 9.9%≈ $1.9m |
| OPTINOSE INC OPTN · 13G · filed 2025-05-14 | 7.8% |
| FEMASYS INC FEMY · 13G · filed 2026-08-31 | 7.2%≈ $2.6m |
| EDESA BIOTECH INC EDSA · 13G · filed 2026-08-26 | 6.9%≈ $5.9m |
| CALCIMEDICA INC 13G · filed 2026-08-25 | 6.0%≈ $2.2m |
| TELA BIO INC TELA · 13G · filed 2025-02-13 | 6.0%≈ $1.8m |
| PASITHEA THERAPEUTICS CORP KTTA · 13G · filed 2026-06-23 | 5.8%≈ $1.0m |